Phase 2 Stomach Cancer Trial, Recruiting (NCT05975749)

Phase 2 Stomach Cancer Trial, Recruiting NCT05975749 Sponsor: Fudan University Condition: Stomach Cancer

Printed from Voxsanity (voxsanity.com.au) — NCT05975749 — Data sourced from ClinicalTrials.gov. Verify directly with the trial site before attending. Not medical advice.

Back to Stomach Cancer

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

You are between 20 and 80 years old
You have been confirmed through biopsy or tissue testing to have stomach cancer (specifically a type called adenocarcinoma) at stage II or III
You have had surgery to completely remove the stomach cancer, including removal of nearby lymph nodes (a specific type of surgery called R0 gastrectomy with D2 lymphadenectomy)
Your cancer has tested positive for a protein called HER2, confirmed through laboratory testing of your tissue
You are generally able to carry out daily activities with little to no limitation, and are expected to live for more than 6 months
Your blood counts, liver function, kidney function, and heart readings (ECG) are within acceptable ranges (confirm with trial site for exact values)

Who may not be able to join:

Your stomach cancer is at stage I or stage IV
You were not able to have the full surgical removal of the cancer and lymph nodes described above
You have more than one primary (original) cancer in your body
You have another serious illness affecting your heart, lungs, kidneys, or liver, or have poorly controlled high blood pressure, diabetes, or a mental health condition
You have previously received chemotherapy, radiation therapy, immunotherapy, or targeted cancer treatment

⚠️ Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.

Last synced 5 July 2026

Phase 2: approximately ~30% of drugs entering this phase reach regulatory approval, based on published industry-wide historical data. This is not specific to this trial.

Phase success rates shown are historical industry-wide averages based on published data. They are not a prediction for this specific trial or your individual situation.

GP referral letter

Print a one-page summary to share with your doctor.

Voxsanity

Clinical trials and treatments, explained plainly · voxsanity.com.au

Date:

To: My Doctor

Re: Clinical trial enquiry

I am writing to enquire about the following clinical trial which may be relevant to my care:

Trial: NCT05975749

Sponsor: Fudan University

Phase: Phase 2

Status: Recruiting

Condition: Stomach Cancer

More information: https://clinicaltrials.gov/study/NCT05975749

Eligibility summary (AI generated)

Written by an AI model from ClinicalTrials.gov eligibility criteria and checked on a sample basis. Please confirm against the original criteria.

Who might be able to join this trial:

You are between 20 and 80 years old
You have been confirmed through biopsy or tissue testing to have stomach cancer (specifically a type called adenocarcinoma) at stage II or III
You have had surgery to completely remove the stomach cancer, including removal of nearby lymph nodes (a specific type of surgery called R0 gastrectomy with D2 lymphadenectomy)
Your cancer has tested positive for a protein called HER2, confirmed through laboratory testing of your tissue
You are generally able to carry out daily activities with little to no limitation, and are expected to live for more than 6 months
Your blood counts, liver function, kidney function, and heart readings (ECG) are within acceptable ranges (confirm with trial site for exact values)

Who may not be able to join:

Your stomach cancer is at stage I or stage IV
You were not able to have the full surgical removal of the cancer and lymph nodes described above
You have more than one primary (original) cancer in your body
You have another serious illness affecting your heart, lungs, kidneys, or liver, or have poorly controlled high blood pressure, diabetes, or a mental health condition
You have previously received chemotherapy, radiation therapy, immunotherapy, or targeted cancer treatment

⚠️ Important: Always verify eligibility with the trial site directly before applying.

Access in Australia: A treatment being studied in a clinical trial is generally not yet listed on the PBS. Where a medicine is not approved or not available through a trial, the TGA Special Access Scheme may allow a doctor to access unapproved therapeutic goods for individual patients. See voxsanity.com.au/sas-navigator/ for a plain English explainer.

This information was sourced from ClinicalTrials.gov via Voxsanity (data last synced 5 July 2026). It is not medical advice. Please verify the trial's current status directly with the trial site before acting.

Trial details

Status

Recruiting

Phase

Phase 2

Sponsor

Fudan University

Registry

ClinicalTrials.gov

Start date

1 January 2023

Est. completion

1 January 2026

Where this trial is recruiting

🇨🇳 China

Primary endpoints

Disease-free survival

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 5 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov